CA Patent

CA2702830C — Topical glycopyrrolate formulations

Assigned to Rose U LLC · Expires 2017-02-28 · 9y expired

What this patent protects

Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treat-ment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. …

USPTO Abstract

Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treat-ment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer.

Drugs covered by this patent

Patent Metadata

Patent number
CA2702830C
Jurisdiction
CA
Classification
—
Expires
2017-02-28
Drug substance claim
No
Drug product claim
No
Assignee
Rose U LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.